by Truveta staff | Oct 2, 2023 | Data
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...
by Truveta staff | Jul 17, 2023 | Data, Technology
Using real-world data to understand a patient’s journey through the healthcare ecosystem can be challenging, particularly for rare or less common diseases. The relevant data are often fragmented, incomplete, and inaccessible—further limiting the data available to...
